Absence of Myocardial Thyroid Hormone Inactivating Deiodinase Results in Restrictive Cardiomyopathy in Mice

• DOI: 10.1210/me.2011-1325
• Publication Date: 2012-03-08T21:48:21Z
• Authors: Cintia B. Ueta; Behzad N. Oskouei; Emerson L. Olivares; Jose R. Pinto; Mayrin M. Correa; Gordana Simovic; Warner S. Simonides; Joshua M. Hare; Antonio C. Bianco
• Keywords: Heart Failure; Male; Mice, Knockout; Cardiomyopathy, Restrictive; 0303 health sciences; Cardiotonic Agents; Dose-Response Relationship, Drug; Ventricular Remodeling; Gene Expression Profiling; Myocardium; Isoproterenol; Muscle Proteins; Heart; Iodide Peroxidase; 3. Good health; Mice, Inbred C57BL; Mice; 03 medical and health sciences; Animals, Newborn; Gene Expression Regulation; Animals; RNA, Messenger; Infusions, Intravenous

Cardiac injury induces myocardial expression of the thyroid hormone inactivating type 3 deiodinase (D3), which in turn dampens local thyroid hormone signaling. Here, we show that the D3 gene (Dio3) is a tissue-specific imprinted gene in the heart, and thus, heterozygous D3 knockout (HtzD3KO) mice constitute a model of cardiac D3 inactivation in an otherwise systemically euthyroid animal. HtzD3KO newborns have normal hearts but later develop restrictive cardiomyopathy due to cardiac-specific increase in thyroid hormone signaling, including myocardial fibrosis, impaired myocardial contractility, and diastolic dysfunction. In wild-type littermates, treatment with isoproterenol-induced myocardial D3 activity and an increase in the left ventricular volumes, typical of cardiac remodeling and dilatation. Remarkably, isoproterenol-treated HtzD3KO mice experienced a further decrease in left ventricular volumes with worsening of the diastolic dysfunction and the restrictive cardiomyopathy, resulting in congestive heart failure and increased mortality. These findings reveal crucial roles for Dio3 in heart function and remodeling, which may have pathophysiologic implications for human restrictive cardiomyopathy.